Question 1

What is the catalog number for AZD-3759?

Accepted Answer

The catalog number for AZD-3759 is 9609-5.

Question 2

Is AZD-3759 in stock?

Accepted Answer

AZD-3759 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What is AZD-3759 used for?

Accepted Answer

AZD-3759 is a potent epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. AZD-3759 binds to and inhibits the activity of EGFR as well as certain mutant forms of EGFR. This prevents EGFR-mediated signaling, and may lead to both induction of cell death and inhibit

Question 4

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

AZD-3759

Product Specifications

Shipping Conditions

Storage Conditions

Shelf Life

Frequently Asked Questions

Explore Other Products

Lentiviral mouse Srp68 shRNA (UAS) - Lentiviral mouse Srp68 shRNA (UAS, iRFP) plasmid

Recombinant Nocardia farcinica Imidazolonepropionase (hutI)

Recombinant Nocardia farcinica Imidazolonepropionase (hutI)

Recombinant Nocardia farcinica Imidazolonepropionase (hutI)

Recombinant Nocardia farcinica Imidazolonepropionase (hutI)

Recombinant Nocardia farcinica Imidazolonepropionase (hutI)